Friendship Forged in Community Leads to Collaborative Cancer Research
June 4, 2026 | Categories: Research, Uncategorized |ISCRM faculty member Thelma Escobar reunites with a long-time friend to map how certain cancer-causing viruses rewire a cell's genes and metabolism during infection and identify possible targets to slow or stop viral replication. Read More
How Studying Cell Fitness in the Early Human Embryo Could Enhance Cancer, Fertility, and Regenerative Medicine Research
December 3, 2025 | Categories: Core Faculty |Dr. Min (Mia) Yang has received an NIH Director’s New Innovator Award that will enable her lab to shed light on the dynamics of chromosomal instability during a narrow, but formative window of time in the early human embryo. Read More
Study from Kueh Lab Describes Surprising Agility in T Cell Threat Assessment
January 11, 2024 | Categories: Core Faculty, Research |New research from the Kueh Lab, published in the journal PNAS, reveals surprising insights about the signaling circuitry that allows T cells to elicit tailored responses to a diverse range of threats and proposes a model for future study. Read More
Undergraduate Students on the Hunt for Cancer Killing Molecules
November 3, 2021 | Categories: Core Faculty |Described in the journal Cells, a multi-year effort to identify molecules that target cancer cells gave UW undergraduates real-world laboratory experience. Read More
Two ISCRM Trainees Named to 2021 Husky 100 List
June 14, 2021 | Categories: Award |ISCRM trainees Eric Scott Nealy, PhD and Kendan Jones-Isaac have been recognized for their contributions to cancer and kidney research. Read More
New Investigator Award for Julie Mathieu Funds Collaborative Cancer Research
June 11, 2021 | Categories: Award, Research |Fueled in part by a New Investigator Award from the Cancer Consortium, ISCRM faculty member Julie Mathieu, PhD is partnering with scientists at the Institute for Protein Design and Fred Hutch to develop new treatments for renal cell carcinoma. Read More
Supercharging Antibodies for Better Medicine
April 2, 2021 | Categories: Uncategorized |Researchers from the Ruohola-Baker Lab have collaborated with the Institute for Protein Design on a technology in which designed proteins assemble antibodies in nanocage structures, increasing their potency against cancer, COVID-19, and other diseases. Read More
Research from Doulatov Lab in the Journal Blood Offers Stem Cell-Aided Insights on MDS Onset
June 13, 2019 | Categories: Research |Myelodysplastic syndromes (MDS) are heterogenous blood disorders that affect up to 170,000 people in the United States, primarily over the age of 60. While early symptoms, including anemia (characterized by fatigue), are not serious, MDS is a high-risk factor for leukemia. Currently there are few treatment for MDS and the causes remain poorly understood. Read More
Studying Cell Signaling in the Prostate
April 15, 2019 | Categories: Core Faculty, Research |While prostate cancer may not be as deadly as other cancers – five-year survival rates can exceed 90%, especially if the disease is localized – incidence rates overall are increasing. For 2019 alone, The American Cancer Society predicts the United States will see roughly 175,000 new cases and 32,000 deaths associated with prostate cancer. Read More